Education for Life Scholarships

Scholarship Sponsored by See the Future Fund

The SEE THE FUTURE Fund is pleased to award scholarships to qualified visually impaired and blind students who are Colorado residents. This scholarship fund is made possible through generous donations by ophthalmologists, optometrists, opticians, staff, corporations, educators, foundations and many others with an interest in the lives of the visually impaired and blind. All scholarships are awarded based on academic achievement, school and community service, and individual need. Scholarships totaling up to $42,000 may be awarded. Probable distribution will be one (1) $12,000 four-year scholarship, one (1) $10,000 four-year scholarship, one (1) $8,000 four-year scholarship, and three (3) $4,000 two-year scholarships. The Selection Committee will determine the final number of scholarships awarded and the amount of each scholarship.

WHO IS ELIGIBLE:

Any Colorado resident who submits a completed application prior to the March 1st deadline, and meets the following criteria:

* For STF purposes, a Colorado resident is one who has lived in Colorado as a dependent at least one year prior to the March 1st deadline; or has held a valid Colorado ID for at least one full year prior to the March 1st deadline.

Educational Criteria:

Applicant must be enrolled as a full-time student in one of the following:

1. an entering freshman in an academic post-secondary program  
2. an undergraduate (sophomore, junior or senior) in an academic, post-secondary program
3. a graduate student in an academic program
4. a vocational/technical school student or student who is pursuing an associate's degree from a community college                                                        
5. Certified Certificate program (such as massage therapy)

Applicants must also meet the following Vision Loss Criteria:

20/70 or less, central vision, best corrected, in better eye, and/or 20-degree peripheral field or less in better eye or 20/40 or less, best corrected, in better eye, and associated field loss with a prognosis of further vision loss secondary to underlying disease process.